List of Excipients in API nitrofurantoin (macrocrystals)
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nitrofurantoin (macrocrystals)
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 | FERRIC OXIDE YELLOW |
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 | FERROSOFERRIC OXIDE |
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 | GELATIN |
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 | LACTOSE MONOHYDRATE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for nitrofurantoin (macrocrystals)
Excipient focus: FERRIC OXIDE RED
nitrofurantoin (macrocrystals) drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-753 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-942 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (macrocrystals) drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-795 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
nitrofurantoin (macrocrystals) drug variants containing FERRIC OXIDE YELLOW
nitrofurantoin (macrocrystals) drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
nitrofurantoin (macrocrystals) drug variants containing FERROSOFERRIC OXIDE
nitrofurantoin (macrocrystals) drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
nitrofurantoin (macrocrystals) drug variants containing GELATIN
nitrofurantoin (macrocrystals) drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
nitrofurantoin (macrocrystals) drug variants containing LACTOSE MONOHYDRATE
nitrofurantoin (macrocrystals) drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
nitrofurantoin (macrocrystals) drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-753 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (macrocrystals) drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-795 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-942 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
nitrofurantoin (macrocrystals) drug variants containing POTASSIUM HYDROXIDE
nitrofurantoin (macrocrystals) drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
nitrofurantoin (macrocrystals) drug variants containing PROPYLENE GLYCOL
nitrofurantoin (macrocrystals) drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
nitrofurantoin (macrocrystals) drug variants containing SHELLAC
nitrofurantoin (macrocrystals) drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
nitrofurantoin (macrocrystals) drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-753 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (macrocrystals) drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-795 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-942 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
nitrofurantoin (macrocrystals) drug variants containing SODIUM LAURYL SULFATE
nitrofurantoin (macrocrystals) drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
nitrofurantoin (macrocrystals) drug variants containing STARCH, CORN
nitrofurantoin (macrocrystals) drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
nitrofurantoin (macrocrystals) drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | nitrofurantoin (macrocrystals) | 50090-7308 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-795 |
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-942 |
| >Company | >Ingredient | >NDC |
nitrofurantoin (macrocrystals) drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | nitrofurantoin (macrocrystals) | 59651-753 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
nitrofurantoin (macrocrystals) drug variants containing TITANIUM DIOXIDE
nitrofurantoin (macrocrystals) drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch